GREENVILLE, S.C., Sept. 28 /PRNewswire/ -- On Oct. 6, Lexicor Medical Technologies will make an important announcement related to regulations and clinical trials of the NeuroLex Indicator Report Service(SM) for Attention Deficit Hyperactivity Disorder (ADHD). This announcement has significant implications for the future of ADHD assessment.
You are invited to join us for this Internet presentation on Thursday, October 6, 2005, at 11:00 a.m. Eastern Standard Time.
What: Lexicor Internet Media Briefing (3-5 minutes in length)
Who: Vince Colwell, Lexicor and Dr. Humberto Quintana, director of the
Louisiana State University Health Science Center
When: Thursday, October 6, 2005 at 11:00 a.m. EST
How: Via the Internet -- Simply log on to the Web at the above address
If you are unable to participate on Oct. 6, the presentation will be archived on the Web, or you can call Mike Crisp at 864-298-1430 to make other arrangements.
The NeuroLex Indicator Report Service(SM) for ADHD is the first scientifically-validated objective and non-invasive assessment aid based upon biological indicators rather than upon subjective pencil/paper tests. It is currently being used by medical providers -- primarily pediatricians -- across the country.
Please visit this Web site to make sure you have the software needed to participate: http://www.videonewswire.com/event.asp?id=30620
Lexicor Medical Technologies, LLC
CONTACT: Mike Crisp, +1-864-298-1430, or email@example.com